We are live on ! Find out more
TMO icon

Thermo Fisher Scientific
TMO

802 hedge funds and large institutions have $30.1B invested in Thermo Fisher Scientific in 2013 Q2 according to their latest regulatory filings, with 802 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

98.94% more ownership

Funds ownership: 0% → 98.94% (+99%)

2% less call options, than puts

Call options by funds: $183M | Put options by funds: $187M

Holders
802
Holders Change
+802
Holders Change %
–
% of All Funds
26.17%
Holding in Top 10
72
Holding in Top 10 Change
+72
Holding in Top 10 Change %
% of All Funds
2.35%
New
802
Increased
–
Reduced
–
Closed
–
Calls
$183M
Puts
$187M
Net Calls
-$3.93M
Net Calls Change
-$3.93M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Massachusetts Financial Services
1
Massachusetts Financial Services
Massachusetts
$2.9B +$2.85B +34,259,433 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$2.2B +$2.16B +25,973,277 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.38B +$1.35B +16,273,555 New
State Street
4
State Street
Massachusetts
$1.21B +$1.19B +14,300,980 New
BIT
5
BlackRock Institutional Trust
California
$811M +$797M +9,580,289 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$755M +$743M +8,920,231 New
Viking Global Investors
7
Viking Global Investors
Connecticut
$735M +$723M +8,689,600 New
Capital Research Global Investors
8
Capital Research Global Investors
California
$725M +$713M +8,567,300 New
GCM
9
Glenview Capital Management
New York
$720M +$708M +8,508,661 New
Eagle Capital Management (New York)
10
Eagle Capital Management (New York)
New York
$486M +$478M +5,743,883 New
PC
11
Paulson & Co
New York
$483M +$475M +5,710,900 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$478M +$470M +5,651,321 New
SC
13
Sculptor Capital
New York
$417M +$411M +4,933,200 New
Northern Trust
14
Northern Trust
Illinois
$405M +$398M +4,781,718 New
Morgan Stanley
15
Morgan Stanley
New York
$387M +$380M +4,570,343 New
Bank of America
16
Bank of America
North Carolina
$347M +$341M +4,101,006 New
BRC
17
Blue Ridge Capital
New York
$346M +$340M +4,085,000 New
FPA
18
First Pacific Advisors
California
$330M +$325M +3,900,300 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$296M +$291M +3,494,390 New
BFA
20
BlackRock Fund Advisors
California
$293M +$289M +3,467,456 New
Wells Fargo
21
Wells Fargo
California
$289M +$284M +3,412,048 New
Ameriprise
22
Ameriprise
Minnesota
$262M +$258M +3,101,040 New
Norges Bank
23
Norges Bank
Norway
$259M +$255M +3,061,846 New
LPC
24
Lone Pine Capital
Connecticut
$234M +$230M +2,766,476 New
CM
25
Corvex Management
New York
$234M +$230M +2,762,844 New
1
2 3 4 5

TMO Hedge Fund Activity: Q2 2013 in Review

802 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2013, worth a combined $30.1B.

Buyers outnumbered sellers: 802 funds opened new TMO positions and 0 closed out — a net gain of 802 holders — while 0 added to existing stakes and 0 trimmed.

  • 802 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $30.1B of Thermo Fisher Scientific stock for Q2 2013.
  • 802 funds opened new Thermo Fisher Scientific positions in Q2 2013 and 0 closed out, a net change of +802 holders.

Based on aggregated 13F filings for Q2 2013.